Western herbalism encompasses the plant medicine traditions of Europe and the Mediterranean world — a continuous thread of empirical knowledge stretching from the ancient Greeks through the medieval herbalists to the scientific phytotherapy of today. Unlike Ayurveda and TCM, which embed herbal medicine within complex philosophical systems, Western herbalism developed along a more pragmatic empirical line: observing what plants do and systematising that knowledge, initially through humoral theory and later through the pharmacological sciences. The tradition is far from dead: an estimated 25% of modern pharmaceutical drugs derive from or were inspired by plant compounds, and clinical phytotherapy is well-established in German-speaking Europe.
De Materia Medica, written by the Greek physician Dioscorides around 70 CE, catalogued approximately 600 plants with their therapeutic uses — and remained the primary reference text for European medicine for 1,500 years. The medieval herbalist tradition built on this foundation, adding the spiritual dimension of the Doctrine of Signatures (the idea that a plant's appearance reveals its therapeutic affinity — walnuts for the brain, eyebright for the eyes) and incorporating monastic healing knowledge accumulated across centuries.
The early modern period brought both the printing press, which democratised herbal knowledge through printed herbals (Culpeper's 1652 Complete Herbal remains in print), and the beginnings of chemical analysis that would eventually separate pharmacology from traditional practice. The late 19th and early 20th centuries saw the systematic isolation of active compounds from plant medicines — morphine from opium, aspirin from willow bark, digitalis from foxglove — creating the pharmaceutical industry while simultaneously dismissing the broader plant as less relevant than the isolated compound.
Modern clinical phytotherapy — most developed in Germany, where the Commission E monographs established evidence standards for herbal medicines in the 1990s — takes a rigorously scientific approach: standardised extracts with defined active compound levels, controlled clinical trials, systematic review of evidence. This approach has produced a credible evidence base for dozens of plant medicines and established herbalism as a legitimate therapeutic option in European integrative medicine.
The limitation of the evidence-based approach is that it tends to reduce complex plants to single compounds — studying the isolated extract rather than the whole plant. Traditional herbalists argue that the full plant contains synergistic compounds whose combined action exceeds that of any single constituent, and that standardised extracts lose some of this synergy. Both positions have merit: the evidence-based approach establishes what can be measured reliably; the traditional whole-plant approach may preserve clinical wisdom that current methods cannot yet capture.